These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation. Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of allogeneic hematopoietic stem cell transplantation in the treatment of 28 patients with hepatitis-related aplastic anemia]. Wang Y; Li J; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):628-634. PubMed ID: 37803835 [No Abstract] [Full Text] [Related]
5. Epidemiology of Lower Respiratory Tract Infections and Community-Acquired Respiratory Viruses in Patients with Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: A Retrospective Cohort Study. Epstein DJ; Liang EC; Sharifi H; Lai YK; Arai S; Graber-Naidich A; Sundaram V; Nelson J; Hsu JL Transplant Cell Ther; 2022 Oct; 28(10):705.e1-705.e10. PubMed ID: 35872303 [TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation. Alkhunaizi M; Patel B; Bueno L; Bhan N; Ahmed T; Arain MH; Saliba R; Rondon G; Dickey BF; Bashoura L; Ost DE; Li L; Wang S; Shpall E; Champlin RE; Mehta R; Popat UR; Hosing C; Alousi AM; Sheshadri A Transplant Cell Ther; 2023 Mar; 29(3):204.e1-204.e7. PubMed ID: 36503180 [TBL] [Abstract][Full Text] [Related]
7. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome. Kwok WC; Liang BM; Lui MMS; Tam TCC; Sim JPY; Tse EWC; Leung AYH; Kwong YL; Lie AKW; Ip MSM; Lam DCL Respirology; 2019 May; 24(5):459-466. PubMed ID: 30663178 [TBL] [Abstract][Full Text] [Related]
8. The predictive value of pulmonary function test before transplantation for chronic pulmonary graft-versus-host-disease after allogeneic hematopoietic stem cell transplantation. Yang L; Cheng J; Li F; Qian R; Zhang X; Jin S; He X; Xu T; Hu X; Ma X; Chen J; Zhu Y; Chen F BMC Pulm Med; 2022 Dec; 22(1):473. PubMed ID: 36510158 [TBL] [Abstract][Full Text] [Related]
9. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience. Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680 [TBL] [Abstract][Full Text] [Related]
10. [Clinical Significance of Serum Immunoglobulin Level after Peri- pheral Blood Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies]. Lin T; Fang S; Wang FY; Gu ZY; Gao XN; Li F; Li M; Huang WR; Liu DH; Gao CJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1774-1781. PubMed ID: 33067989 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation. Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823 [TBL] [Abstract][Full Text] [Related]
13. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Sengsayadeth SM; Srivastava S; Jagasia M; Savani BN Biol Blood Marrow Transplant; 2012 Oct; 18(10):1479-87. PubMed ID: 22449611 [TBL] [Abstract][Full Text] [Related]
14. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Ahn JH; Jo KW; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH Clin Transplant; 2015 Dec; 29(12):1133-9. PubMed ID: 26383085 [TBL] [Abstract][Full Text] [Related]
15. A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms. Kordjazy N; Amini S Ther Adv Respir Dis; 2024; 18():17534666241232284. PubMed ID: 38504551 [TBL] [Abstract][Full Text] [Related]